BAYER HLTHCARE FDA Approval NDA 021085

NDA 021085

BAYER HLTHCARE

FDA Drug Application

Application #021085

Documents

Letter2002-06-12
Letter2003-03-10
Letter2004-05-26
Letter2004-03-10
Letter2004-07-30
Letter2005-06-14
Letter2005-11-30
Letter2005-11-30
Letter2007-06-04
Letter2008-02-20
Letter2008-10-07
Letter2009-06-29
Letter2010-11-02
Letter2010-04-09
Letter2011-03-02
Letter2011-10-20
Letter2012-08-28
Label2003-02-28
Label2004-05-27
Label2004-04-05
Label2004-07-30
Label2005-11-30
Label2005-11-30
Label2008-02-25
Label2009-05-15
Label2010-10-25
Label2009-12-02
Label2011-10-20
Label2011-10-20
Label2013-08-15
Label2016-07-26
Review2004-05-27
Review2008-02-19
Letter1999-12-10
Letter2002-06-12
Letter2001-04-27
Letter2002-05-16
Letter2003-03-10
Letter2003-03-10
Letter2003-10-06
Letter2008-12-31
Letter2009-05-05
Letter2010-01-25
Letter2011-08-08
Letter2011-10-20
Letter2012-12-26
Letter2013-08-16
Letter2014-11-24
Letter2015-05-13
Letter2016-07-26
Label1999-12-10
Label2002-06-12
Label2002-06-12
Label2001-04-27
Label2002-05-16
Label2003-02-28
Label2003-02-28
Label2003-10-10
Label2005-06-14
Label2007-06-04
Label2009-01-02
Label2008-10-09
Label2010-03-05
Label2011-03-04
Label2012-09-11
Label2012-12-21
Label2014-12-03
Label2015-06-05
Review2004-05-27
Label2016-09-30
Label2016-09-30
Letter2016-09-30
Letter2016-09-30
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Label2018-10-19
Letter2018-10-23
Letter2019-05-06
Label2019-05-08
Medication Guide2019-05-08
Letter2020-05-07
Label2020-05-06
Medication Guide2020-05-07

Application Sponsors

NDA 021085BAYER HLTHCARE

Marketing Status

Discontinued001

Application Products

001TABLET;ORALEQ 400MG BASE1AVELOXMOXIFLOXACIN HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1999-12-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2000-04-21STANDARD
LABELING; LabelingSUPPL4AP2001-05-17STANDARD
LABELING; LabelingSUPPL5AP2001-05-17STANDARD
LABELING; LabelingSUPPL6AP2002-06-12STANDARD
LABELING; LabelingSUPPL7AP2002-06-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2001-02-02STANDARD
LABELING; LabelingSUPPL10AP2001-04-27STANDARD
LABELING; LabelingSUPPL12AP2002-05-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2002-12-10STANDARD
LABELING; LabelingSUPPL14AP2003-02-28STANDARD
EFFICACY; EfficacySUPPL15AP2003-02-28STANDARD
LABELING; LabelingSUPPL17AP2003-02-28STANDARD
LABELING; LabelingSUPPL19AP2003-10-06STANDARD
EFFICACY; EfficacySUPPL22AP2004-05-18PRIORITY
LABELING; LabelingSUPPL23AP2004-03-06STANDARD
LABELING; LabelingSUPPL24AP2004-07-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2004-12-14STANDARD
EFFICACY; EfficacySUPPL26AP2005-06-13UNKNOWN
EFFICACY; EfficacySUPPL27AP2005-11-22UNKNOWN
LABELING; LabelingSUPPL29AP2005-11-22STANDARD
LABELING; LabelingSUPPL36AP2007-05-31STANDARD
LABELING; LabelingSUPPL38AP2008-02-15STANDARD
LABELING; LabelingSUPPL39AP2008-12-29STANDARD
LABELING; LabelingSUPPL40AP2008-10-03STANDARD
LABELING; LabelingSUPPL41AP2009-06-24STANDARD
LABELING; LabelingSUPPL42AP2009-04-27STANDARD
LABELING; LabelingSUPPL44AP2010-10-25STANDARD
LABELING; LabelingSUPPL45AP2009-11-24UNKNOWN
LABELING; LabelingSUPPL46AP2010-03-02UNKNOWN
LABELING; LabelingSUPPL47AP2011-02-25901 REQUIRED
LABELING; LabelingSUPPL50AP2011-10-18STANDARD
REMS; REMSSUPPL52AP2011-08-03N/A
LABELING; LabelingSUPPL53AP2011-10-18UNKNOWN
LABELING; LabelingSUPPL55AP2012-08-24STANDARD
LABELING; LabelingSUPPL56AP2012-12-18STANDARD
LABELING; LabelingSUPPL57AP2013-08-14901 REQUIRED
MANUF (CMC); Manufacturing (CMC)SUPPL58AP2014-11-19STANDARD
LABELING; LabelingSUPPL59AP2014-11-20STANDARD
EFFICACY; EfficacySUPPL60AP2015-05-08STANDARD
EFFICACY; EfficacySUPPL61AP2016-09-27PRIORITY
LABELING; LabelingSUPPL62AP2016-09-27STANDARD
LABELING; LabelingSUPPL63AP2016-07-26STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
LABELING; LabelingSUPPL64AP2018-10-18STANDARD
LABELING; LabelingSUPPL65AP2019-05-03STANDARD
LABELING; LabelingSUPPL66AP2020-05-06STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL8Null0
SUPPL13Null0
SUPPL23Null9
SUPPL25Null0
SUPPL42Null7
SUPPL44Null7
SUPPL45Null6
SUPPL46Null6
SUPPL47Null6
SUPPL50Null7
SUPPL52Null6
SUPPL53Null6
SUPPL55Null7
SUPPL56Null7
SUPPL57Null7
SUPPL58Null0
SUPPL59Null15
SUPPL60Null15
SUPPL61Null6
SUPPL62Null7
SUPPL63Null15
SUPPL64Null6
SUPPL65Null6
SUPPL66Null6

TE Codes

001PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21085
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.